AbbVie (ABBV) Debt Ratio (2012 - 2026)
AbbVie (ABBV) reported Debt Ratio of 0.47 for Q1 2026, down 5.72% year-over-year from 0.5 in Q1 2025, and up 3.11% quarter-over-quarter from 0.46 in Q4 2025.
AbbVie (ABBV) Debt Ratio (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has 15 years of Debt Ratio data on file, last reported at 0.47 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.47, down 5.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.47 (down 5.72% YoY), and the FY2025 annual result was 0.46, down 7.67% from the prior year.
- Debt Ratio improved to 0.47 in Q1 2026 per ABBV's latest filing, from 0.46 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.51 in Q2 2022 and troughed at 0.41 in Q2 2023.
- A 5-year average of 0.47 and a median of 0.46 in 2023 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio dropped 21.93% in 2022, then climbed 20.7% in 2024.
- A 5-year view of Debt Ratio shows it stood at 0.46 in 2022, then decreased by 3.29% to 0.44 in 2023, then advanced by 12.69% to 0.5 in 2024, then slipped by 7.67% to 0.46 in 2025, then rose by 3.11% to 0.47 in 2026.
- Business Quant data shows ABBV's Debt Ratio at 0.47 in Q1 2026, 0.46 in Q4 2025, and 0.49 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -0.22 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 0.37 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 0.27 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 0.47 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 0.31 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 0.51 |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.51 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | 0.54 |
| Jun 30, 2021 | 0.55 |